Analyst Recommendations

RBC Capital analyst issues UNDERPERFORM recommendation for LEN on March 13, 2024 10:38AM ET. The previous analyst recommendation was Underperform.LEN was trading at $166.17 at issue of the...

March 13, 2024   LEN -0.82%

Barclays analyst issues OVERWEIGHT recommendation for LEN on March 13, 2024 10:38AM ET. The previous analyst recommendation was Overweight.LEN was trading at $166.17 at issue of the analyst...

March 13, 2024   LEN -0.82%

Wells Fargo analyst issues OVERWEIGHT recommendation for LEN on March 13, 2024 10:38AM ET. The previous analyst recommendation was Overweight.LEN was trading at $166.17 at issue of the...

March 13, 2024   LEN -0.82%

Barclays analyst issues OVERWEIGHT recommendation for LEN on March 13, 2024 10:38AM ET. The previous analyst recommendation was Overweight.LEN was trading at $166.17 at issue of the analyst...

March 13, 2024   LEN -0.82%

RBC Capital analyst issues UNDERPERFORM recommendation for LEN on March 13, 2024 10:38AM ET. The previous analyst recommendation was Underperform.LEN was trading at $166.17 at issue of the...

March 13, 2024   LEN -0.82%

Raymond James analyst issues OUTPERFORM recommendation for LEN on March 13, 2024 10:38AM ET. The previous analyst recommendation was Outperform.LEN was trading at $166.17 at issue of the...

March 13, 2024   LEN -0.82%

Wells Fargo analyst issues OVERWEIGHT recommendation for LEN on March 13, 2024 10:38AM ET. The previous analyst recommendation was Overweight.LEN was trading at $166.17 at issue of the...

March 13, 2024   LEN -0.82%

Wedbush analyst issues NEUTRAL recommendation for LEN on March 13, 2024 10:38AM ET. The previous analyst recommendation was Neutral.LEN was trading at $166.17 at issue of the analyst...

March 13, 2024   LEN -0.82%

Wolfe Research analyst issues OUTPERFORM recommendation for BA on March 13, 2024 08:51AM ET. The previous analyst recommendation was Outperform.BA was trading at $184.24 at issue of the...

March 13, 2024   BA 0.74%

Morgan Stanley analyst issues OVERWEIGHT recommendation for REGN on March 13, 2024 08:51AM ET. The previous analyst recommendation was Overweight.REGN was trading at $970.57 at issue of the...

March 13, 2024   REGN 2.99%